Stock trading under $1 per share since July.
Health Care + Med Tech
Medtech company tapped new CEO in July.
Report says reporting requirements may trip up otherwise compliant businesses.
Jacksonville team’s latest describes drug treatment for frontotemporal dementia.
Provides web-based tool to help hospitals reduce ‘adverse events.'
Sales of drug-eluting stents, insulin pumps and other products didn’t grow at the pace Medtronic expected, sending the company’s revenue below its own expectations.
The medical devices manufacturer previously said it would detail its integration plan for EndoChoice’s product line, but elected to push back that announcement to the end of the year.
The medical device company also added two new board members, one of which is Marilyn Carlson Nelson, the former CEO of hospitality company Carlson.
The company’s flagship Diamondback 360 coronary device is expected to receive Shonin approval, which, if it does, will mark Cardiovascular Systems’ first step into an international market.
Study hints employers may need to increase incentives to use low-cost retail clinics for routine care.
They say benefits from sequencing genomes can’t be widely applied without changes.
The health system brought in about 1,200 replacement nurses during the two strikes this summer and fall.
The gene-editing company also signed Capitol Peak Asset Management to be its advisor on all future capitalization and strategic transactions.
The hospital system has adopted a number of different names since its founding in 1887 as Minneapolis City Hospital.
Patients face safety risks from health technologies designed to improve care.
Patent filed for ‘smart’ polymer that could have big implications for pharma pipelines.
Based on Mayo ‘cell senescence’ research, San Francisco-based Unity Biotechnology rakes in $116 million financing.
The sleep apnea specialist is looking to raise a total of $37.5 million in its latest investment round.